Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ, et al. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St. Gallen international expert consensus on the primary therapy of early breast cancer 2011. Ann Oncol. 2011;22:1736–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Won KA, Spruck C. Triple‑negative breast cancer therapy: current and future perspectives (Review). Int J Oncol. 2020;57:1245–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kojima T, Morikawa Y, Copeland NG, Gilbert DJ, Jenkins NA, Senba E, et al. TROY, a newly identified member of the tumor necrosis factor receptor superfamily, exhibits a homology with Edar and is expressed in embryonic skin and hair follicles. J Biol Chem. 2000;275:20742–7.

Article  CAS  PubMed  Google Scholar 

Eby MT, Jasmin A, Kumar A, Sharma K, Chaudhary PM. TAJ, a novel member of the tumor necrosis factor receptor family, activates the c-Jun N-terminal kinase pathway and mediates caspase-independent cell death. J Biol Chem. 2000;275:15336–42.

Article  CAS  PubMed  Google Scholar 

Dostert C, Grusdat M, Letellier E, Brenner D. The TNF family of ligands and receptors: communication modules in the immune system and beyond. Physiol Rev. 2019;99:115–60.

Article  CAS  PubMed  Google Scholar 

Sperandio S, Poksay K, de Belle I, Lafuente MJ, Liu B, Nasir J, et al. Paraptosis: mediation by MAP kinases and inhibition by AIP-1/Alix. Cell Death Differ. 2004;11:1066–75.

Article  CAS  PubMed  Google Scholar 

Wang Y, Wen X, Zhang N, Wang L, Hao D, Jiang X, et al. Small-molecule compounds target paraptosis to improve cancer therapy. Biomed Pharmacother. 2019;118:109203.

Article  CAS  PubMed  Google Scholar 

Wang L, Gundelach JH, Bram RJ. Cycloheximide promotes paraptosis induced by inhibition of cyclophilins in glioblastoma multiforme. Cell Death Dis. 2017;8:e2807.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee D, Kim IY, Saha S, Choi KS. Paraptosis in the anti-cancer arsenal of natural products. Pharm Ther. 2016;162:120–33.

Article  CAS  Google Scholar 

Ram BM, Ramakrishna G. Endoplasmic reticulum vacuolation and unfolded protein response leading to paraptosis like cell death in cyclosporine A treated cancer cervix cells is mediated by cyclophilin B inhibition. Biochim Biophys Acta. 2014;1843:2497–512.

Article  CAS  PubMed  Google Scholar 

Hoa N, Myers MP, Douglass TG, Zhang JG, Delgado C, Driggers L, et al. Molecular mechanisms of paraptosis induction: implications for a non-genetically modified tumor vaccine. PLoS One. 2009;4:e4631.

Article  PubMed  PubMed Central  Google Scholar 

Chung AH, Leisner TM, Dardis GJ, Bivins MM, Keller AL, Parise LV. CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death. Cancer Cell Int. 2019;19:26.

Article  PubMed  PubMed Central  Google Scholar 

Wang Y, Li X, Wang L, Ding P, Zhang Y, Han W, et al. An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression. J Cell Sci. 2004;117:1525–32.

Article  CAS  PubMed  Google Scholar 

Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173:400–16.e11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2000 breast tumours reveals novel subgroups. Nature. 2012;486:346–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chalmers ZR, Connelly CF, Fabrizio D, Gay L, Ali SM, Ennis R, et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med. 2017;9:34.

Article  PubMed  PubMed Central  Google Scholar 

Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24:1550–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein JN, et al. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell. 2018;173:338–54.e15.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pizato N, Luzete BC, Kiffer L, Correa LH, de Oliveira Santos I, Assumpcao JAF, et al. Omega-3 docosahexaenoic acid induces pyroptosis cell death in triple-negative breast cancer cells. Sci Rep. 2018;8:1952.

Article  PubMed  PubMed Central  Google Scholar 

Zhang Z, Zhang H, Li D, Zhou X, Qin Q, Zhang Q. Caspase-3-mediated GSDME induced Pyroptosis in breast cancer cells through the ROS/JNK signalling pathway. J Cell Mol Med. 2021;25:8159–68.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ekstrand J, Zemmler M, Abrahamsson A, Lundberg P, Forsgren M, Dabrosin C. Breast density and estradiol are major determinants for soluble TNF-TNF-R proteins in vivo in human breast tissue. Front Immunol. 2022;13:850240.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo L, Gao R, Gan J, Zhu Y, Ma J, Lv P, et al. Downregulation of TNFRSF19 and RAB43 by a novel miRNA, miR-HCC3, promotes proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma cells. Biochem Biophys Res Commun. 2020;525:425–32.

Article  CAS  PubMed  Google Scholar 

Wilhelm F, Boger C, Kruger S, Behrens HM, Rocken C. Troy is expressed in human stomach mucosa and a novel putative prognostic marker of intestinal type gastric cancer. Oncotarget. 2017;8:50557–69.

Article  PubMed  Google Scholar 

Shao L, Zuo X, Yang Y, Zhang Y, Yang N, Shen B, et al. The inherited variations of a p53-responsive enhancer in 13q12.12 confer lung cancer risk by attenuating TNFRSF19 expression. Genome Biol. 2019;20:103.

Article  PubMed  PubMed Central  Google Scholar 

Spanjaard RA, Whren KM, Graves C, Bhawan J. Tumor necrosis factor receptor superfamily member TROY is a novel melanoma biomarker and potential therapeutic target. Int J Cancer. 2007;120:1304–10.

Article  CAS  PubMed  Google Scholar 

Ding Z, Dhruv H, Kwiatkowska-Piwowarczyk A, Ruggieri R, Kloss J, Symons M, et al. PDZ-RhoGEF is a signaling effector for TROY-induced glioblastoma cell invasion and survival. Neoplasia. 2018;20:1045–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Paulino VM, Yang Z, Kloss J, Ennis MJ, Armstrong BA, Loftus JC, et al. TROY (TNFRSF19) is overexpressed in advanced glial tumors and promotes glioblastoma cell invasion via Pyk2-Rac1 signaling. Mol Cancer Res. 2010;8:1558–67.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ding Z, Roos A, Kloss J, Dhruv H, Peng S, Pirrotte P, et al. A novel signaling complex between TROY and EGFR mediates glioblastoma cell invasion. Mol Cancer Res. 2018;16:322–32.

Article  CAS  PubMed  Google Scholar 

Deng C, Lin YX, Qi XK, He GP, Zhang Y, Zhang HJ, et al. TNFRSF19 inhibits TGFbeta signaling through interaction with TGFbeta receptor type I to promote tumorigenesis. Cancer Res. 2018;78:3469–83.

Article  CAS  PubMed  Google Scholar 

Saberi S, Piryaei A, Mirabzadeh E, Esmaeili M, Karimi T, Momtaz S, et al. Immunohistochemical analysis of LGR5 and TROY expression in gastric carcinogenesis demonstrates an inverse trend. Iran Biomed J. 2019;23:107–20.

Article  PubMed  PubMed Central  Google Scholar 

Mimnaugh EG, Xu W, Vos M, Yuan X, Neckers L. Endoplasmic reticulum vacuolization and valosin-containing protein relocalization result from simultaneous hsp90 inhibition by geldanamycin and proteasome inhibition by velcade. Mol Cancer Res. 2006;4:667–81.

Article  CAS  PubMed  Google Scholar 

Kolb PS, Ayaub EA, Zhou W, Yum V, Dickhout JG, Ask K. The therapeutic effects of 4-phenylbutyric acid in maintaining proteostasis. Int J Biochem Cell Biol. 2015;61:45–52.

Article  CAS  PubMed  Google Scholar 

Li GN, Zhao XJ, Wang Z, Luo MS, Shi SN, Yan DM, et al. Elaiophylin triggers paraptosis and preferentially kills ovarian cancer drug-resistant cells by inducing MAPK hyperactivation. Signal Transduct Target Ther. 2022;7:317.

Article  CAS  PubMed Central  Google Scholar